What amount sold does INNOVUS PHARMACEUTICALS, INC. report in Form D filings?

The latest linked filings report $14.7M sold across 18 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was INNOVUS PHARMACEUTICALS, INC.'s most recent SEC filing?

INNOVUS PHARMACEUTICALS, INC.'s most recent Form D filing was on 2019-01-11.

How many investors does INNOVUS PHARMACEUTICALS, INC. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does INNOVUS PHARMACEUTICALS, INC. offer?

INNOVUS PHARMACEUTICALS, INC.'s SEC Form D filings indicate equity offerings.

INNOVUS PHARMACEUTICALS, INC.

CIK: 0001411879·Pharmaceuticals·San Diego, CA·Corporation

Reported Sold

$14,668,914

Total Filings

Identified Offerings

Last Filed

Jan 11, 2019

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Jan 11, 2019Form D — New notice

Reported sold: $3,171,445 · Target: $3,171,445

Rule 506(b)·1 investor

Aug 2, 2017Form D — New notice

Reported sold: $145,200 · Target: $145,200

Rule 506(b)·1 investor

Aug 2, 2016Form D — New notice

Reported sold: $3,000,000 · Target: $3,000,000

Rule 506(b)·9 investors

Aug 6, 2015Form D — New notice

Reported sold: $16,000 · Target: $16,000

Rule 506(b)·0 investors

Aug 6, 2015Form D — New notice

Reported sold: $500,000 · Target: $1,500,000

Rule 506(b)·0 investors

Feb 25, 2014Form D — New notice

Reported sold: $330,000 · Target: $330,000

Rule 506(b)·1 investor

Feb 25, 2014Form D — New notice

Reported sold: $742,300 · Target: $742,300

Rule 506(b)·6 investors

Jan 7, 2014Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(b)·28 investors

Jan 7, 2014Form D — New notice

Reported sold: $350,000 · Target: $350,000

Rule 506(b)·1 investor

Aug 28, 2013Form D — New notice

Reported sold: $50,000 · Target: $50,000

Rule 506·1 investor

Aug 28, 2013Form D — New notice

Reported sold: $1,070,000 · Target: $1,070,000

Rule 506·2 investors

Aug 28, 2013Form D — New notice

Reported sold: $174,668 · Target: $174,668

Rule 506·6 investors

Aug 28, 2013Form D — New notice

Reported sold: $50,000 · Target: $50,000

Rule 506·1 investor

Aug 28, 2013Form D/A — Amendment

Reported sold: $50,000 · Target: $50,000

Rule 506·1 investor

Aug 26, 2013Form D — New notice

Reported sold: $134,640 · Target: $134,640

Rule 506·2 investors

Aug 26, 2013Form D — New notice

Reported sold: $4,484,661 · Target: $6,000,000

Rule 506·6 investors

May 20, 2013Form D — New notice

Reported sold: $450,000 · Target: $450,000

Rule 506·1 investor

May 30, 2012Form D — New notice

Reported sold: $0 · Target: $1,100,000

Rule 506·0 investors

Mar 23, 2012Form D — New notice

Reported sold: $0 · Target: $0

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$5,000,001 - $25,000,000

Reported commissions across identified offerings

$354,572

Amendment Rate

Latest reported sold across 18 identified offerings

$14,668,914

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Bassam Damaj

Related Person

Appears on 10 filings

Vivian Liu

Related Person

Appears on 9 filings

Ziad Mirza

Related Person

Appears on 9 filings

Henry Esber

Related Person

Appears on 9 filings

Bassam Damaj

Related Person

Appears on 7 filings

Morgan Reed Brown

Related Person

Appears on 7 filings

Henry Esber

Related Person

Appears on 5 filings

Vivian Liu

Related Person

Appears on 5 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 11, 2019	New	$3,171,445	$3,171,445	1
Aug 2, 2017	New	$145,200	$145,200	1
Aug 2, 2016	New	$3,000,000	$3,000,000	9
Aug 6, 2015	New	$16,000	$16,000	0
Aug 6, 2015	New	$1,500,000	$500,000	0
Feb 25, 2014	New	$742,300	$742,300	6
Feb 25, 2014	New	$330,000	$330,000	1
Jan 7, 2014	New	Indefinite	$0	28
Jan 7, 2014	New	$350,000	$350,000	1
Aug 28, 2013	Amendment	$50,000	$50,000	1
Aug 28, 2013	New	$1,070,000	$1,070,000	2
Aug 28, 2013	New	$50,000	$50,000	1
Aug 28, 2013	New	$50,000	$50,000	1
Aug 28, 2013	New	$174,668	$174,668	6
Aug 26, 2013	New	$134,640	$134,640	2
Aug 26, 2013	New	$6,000,000	$4,484,661	6
May 20, 2013	New	$450,000	$450,000	1
May 30, 2012	New	$1,100,000	$0	0
Mar 23, 2012	New	$0	$0	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Jaguar Health, Inc.

Pharmaceuticals

Offering target: $2,000,000

Filed Jun 30, 2026